Peptide Initiative

Peptides · Peptide comparison

Crystagen vs Thymalin

Immunogeroprotective tripeptide bioregulator (Glu-Asp-Pro) that optimally stimulates thymic epithelial cell proliferation at 200 ng/mL, suppresses thymocyte apoptosis through p53 downregulation and Ki-67 upregulation, and contributed to a 4.1-fold mortality reduction in a 266-person 6-8 year clinical study when combined with complementary pineal peptides

Russian thymic peptide complex that rejuvenates immune function and supports healthy aging

  • Immune
  • Immune

At a glance

Quick comparison

Dose rangeCrystagen200–400 mcgThymalin5–10 mg
FrequencyCrystagenOnce dailyThymalinOnce daily
AdministrationCrystagenSubcutaneous injectionThymalinIntramuscular injection
Cycle lengthCrystagen8-12 weeksThymalin4-6 weeks
Onset speedCrystagenGradual (3-4 weeks)ThymalinModerate (1-2 weeks)
Evidence levelCrystagenLimited human trialsThymalinLimited human trials

Efficacy

Benefit ratings

Immune Rejuvenation

Crystagen94%
ThymalinNo recorded rating

Healthy Aging

Crystagen91%
ThymalinNo recorded rating

Cancer Defense

Crystagen85%
ThymalinNo recorded rating

Immune Restoration

CrystagenNo recorded rating
Thymalin88%

Longevity Support

CrystagenNo recorded rating
Thymalin82%

Disease Prevention

CrystagenNo recorded rating
Thymalin78%

Technical data

Compound specifications

Crystagen

Molecular formula
C14H21N3O8
Molecular weight
359.3 g/mol
Half-life
Short plasma half-life typical of tripeptides (minutes); biological effects persist for weeks to months through gene expression modifications and thymic microenvironment restoration; metabolized to constituent amino acids
Bioavailability
Absorbed via intestinal peptide transporters (PepT1/POT and LAT carrier families) when administered orally; rapid absorption from subcutaneous injection sites; efficient cellular uptake due to ultra-short tripeptide structure
CAS number
Not assigned (patented as immunogeroprotective peptide, US8057810B2)

Thymalin

Molecular formula
Complex mixture; active dipeptide EW: C16H19N3O5
Molecular weight
Polypeptide complex; components 250-1000 Da; active dipeptide EW ~321 Da
Half-life
Not precisely characterized for complex; immune effects persist weeks post-administration
Bioavailability
High via intramuscular or subcutaneous injection
CAS number
63958-90-7

Protocols

Dosing compared

Crystagen

Subcutaneous

  • 200-400 mcgOnce daily · 10-20 days per course, repeated every 4-6 monthsFor the synthetic peptide form, a dose commonly used in research practice given as an injection under the skin. [6]

Intramuscular

  • 200-400 mcgOnce daily · 10-20 days per course, repeated every 4-6 monthsCan also be given as an intramuscular injection at a similar dose, used in research practice. [6]

Oral

  • 1-2 capsules (10 mg each)1-2 times daily with meals · 10-30 day course, repeated every 4-6 monthsThe oral capsule plan used in practice. Each Cytogen capsule holds 10 mg, delivering about 200-400 mcg of active peptide per dose. [6]

Thymalin

Intramuscular injection

  • 5-10 mg reconstituted in salineOnce daily · 5-10 day course, often repeated every 6 monthsReflects the Russian clinical course used in immune-restoration and gerontology protocols, typically 10 mg IM daily for 5-10 days [1].

Subcutaneous injection

  • 10 mgOnce daily · Up to 20 day course, repeated every 6 monthsSubcutaneous administration is used in community practice at the same 10 mg daily dosing; longer 20-day courses are described for cyclical immune support [1].

Applications

Best suited for

Crystagen

Restoring thymic function and immune competence in aging individuals with immune senescence
Crystagen is particularly well-suited for individuals focused on restoring thymic function and immune competence in aging individuals with immune senescence. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Comprehensive Khavinson bioregulator protocols for immune and anti-aging support
Crystagen is particularly well-suited for individuals focused on comprehensive khavinson bioregulator protocols for immune and anti-aging support. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Supporting immune function during and after illness recovery
Crystagen is particularly well-suited for individuals focused on supporting immune function during and after illness recovery. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Geroprotective immunomodulation to extend healthspan and reduce age-related disease incidence
Crystagen is particularly well-suited for individuals focused on geroprotective immunomodulation to extend healthspan and reduce age-related disease incidence. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.

Thymalin

Aging Adults Seeking Immune Support
Thymalin is especially valuable for people over 55 whose thymus gland has naturally shrunk with age. By stimulating thymic function, it helps restore the immune training center that your body relies on to fight infections and stay healthy.
Longevity and Anti-Aging Protocols
Clinical studies tracking patients for 6-8 years showed Thymalin reduced mortality by 2.0-2.1-fold. Combined with Epitalon, the mortality reduction reached an impressive 4.1-fold, making this combination one of the most studied longevity peptide protocols.
Seasonal Illness Prevention
Research shows Thymalin cuts respiratory infection rates by 2.0-2.4-fold. A short 10-day course before cold and flu season can significantly boost your immune defenses for months afterward.

Safety profile

Side effects

Crystagen

Common

  • Injection site reaction
  • Mild fatigue
  • Mild headache
  • Minor digestive changes

Uncommon

  • Flu-like symptoms

Serious

  • No documented serious adverse effects

Thymalin

Common

  • No side effects in most patients
  • Mild injection site reaction

Uncommon

  • Transient low-grade fever
  • Mild flu-like symptoms
  • Temporary headache

Serious

  • Severe allergic reaction

Research status

Safety & evidence

Crystagen

Evidence level
Limited human trials
FDA status
Research compound
Safety overview
Crystagen is a crystalline protein extract (likely containing collagen-derived peptides) from animal tissues that is not FDA-approved and has essentially no published safety data in medical literature. As an undefined and poorly characterized biological mixture, batch consistency, sterility, and identity cannot be verified. Potential risks include allergic reactions to animal proteins, contamination from source tissues, and unknown immunological effects. No formal safety assessments, animal studies, toxicology screening, or human clinical trials exist. The product appears to exist primarily in Russian medical markets, and little information about its actual composition or manufacturing is publicly available.

Contraindications

  • Known hypersensitivity to peptide bioregulators or constituent amino acids (glutamic acid, aspartic acid, proline)
  • Pregnancy and breastfeeding — insufficient reproductive safety data
  • Active autoimmune disease in flare without physician supervision
  • Organ transplant recipients on immunosuppression — potential interference with immunosuppressive regimens

Thymalin

Evidence level
Limited human trials
FDA status
Research compound
Safety overview
Thymalin has an excellent safety profile based on over 40 years of clinical use in Russia. Most patients experience zero side effects, and the peptide complex has been described as 'practically non-toxic' in research literature. It has been used safely in thousands of patients, including elderly populations over extended periods.

Contraindications

  • Active thymic tumors or malignancies
  • Known hypersensitivity to animal-derived peptide products
  • Pregnancy and breastfeeding (insufficient safety data)
  • Severe uncontrolled autoimmune disease without medical supervision

Decision guide

Which is right for you?

Crystagen

Choose Crystagen if…

  • Restoring thymic function and immune competence in aging individuals with immune senescence
  • Comprehensive Khavinson bioregulator protocols for immune and anti-aging support
  • Supporting immune function during and after illness recovery
  • Geroprotective immunomodulation to extend healthspan and reduce age-related disease incidence

Thymalin

Choose Thymalin if…

  • Immune system restoration in aging adults
  • Longevity and healthy aging support
  • Reducing infection frequency and severity
  • Multi-system health optimization